ORMP — ORAMED PHARM INC

Ownership history in TWO SIGMA SECURITIES, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in ORAMED PHARM INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2015 Q1)
Avg. % of fund
0.03%
First filed
2015 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 23,143 +10,181 +78.5% 0.01% $66K $2.66
2023 Q1 ADDED 12,962 +1,123 +9.5% 0.00% $28K $2.03
2015 Q1 INITIATED 11,839 — — 0.08% $75K $5.94
% of Fund (quarterly)    ORMP price (monthly, adj. close)

Other funds also holding ORMP

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 7.8% SB Capital Management Inc 1.98% Murchinson Ltd. 3Y 0.61% Redwood Family Wealth LLC 0.06% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.03% Sage Capital Management, LLC 0.02% Glass Jacobson Investment Advisors llc 3Y 0.01% RBF Capital, LLC 3Y 7Y 0.01% PRELUDE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0%
← Back to TWO SIGMA SECURITIES, LLC Holdings